eClinical Solutions Market worth $5 Billion by 2018

The “eClinical Solutions Market (CDMS/EDC, CTMS, Ecoa , Randomization & Trial Supply Management, Safety), Services, Buyers (Pharma/Biopharma, CROS, Healthcare Providers), Delivery Modes (Web Hosted, On-Premise, Cloud-Based) - Global Forecast to 2018”, This report studies the global eClinical solutions market over the forecast period of 2013 to 2018. The market is expected to reach ~$5 billion by 2018, at a CAGR of 13.5% from 2013 to 2018.

Browse 56 market data tables and 48 figures spread through 244 pages and in-depth TOC on “eClinical Solutions Market"
Early buyers will receive 10% customization on this report.

The global eClinical solutions market is divided into two segments, namely, products market and professional services market. The products market has been further classified into clinical data management systems (CDMS)/electronic data capture (EDC), clinical trial management systems (CTMS), electronic clinical outcome assessment (eCOA), randomization and trial supply management (RTSM), safety solutions, and others. The others segment consists of core lab integration systems, regulatory information management services, and coding systems. The professional services segment includes implementation services, training, support services, and consulting.

Based on the type of buyer, the global eClinical solutions market is segmented into pharmaceutical/biopharmaceutical/medical device companies, clinical research organizations (CROs), and healthcare providers. Based on the type of delivery mode, the global eClinical solutions market is classified as web-based, on-premise, and cloud-based eClinical solutions.

Talk to Our Research Analysts for More Info@

A number of factors such as the increasing pressure for reducing the cost and time consumed during clinical trial processes; rising need for improved data standardization in terms of improving and maintaining the quality of clinical trial procedures to meet regulatory requirements; government grants and initiatives to support drug development; increasing adoption of cloud-based eClinical solutions; and significant spending on clinical research and development by pharmaceutical and biopharmaceutical industries are driving the growth of the eClinical solutions market. On the other hand, factors such as the high capital requirement for implementation of eClinical systems and the growing burden on clinical research teams in terms of skilled labor force and training are restricting the growth of this market. However, a number of factors such as, growth in the number of clinical researches in emerging regions, increasing adoption of cloud technology for the development of eClinical suits, and shifting trend of clinical resources from AMCs (Academic Medical Centers) to CROs are expected to offer high growth opportunities for eClinical solution vendors.

As of 2013, North America held the largest share of ~60.1% in the global eClinical solutions market, followed by Europe (26.4%). However, the Asia-Pacific market is expected to grow at the highest CAGR of ~19.5% from 2013 to 2018. A number of factors such as, presence of a large patient population, faster recruitment of patients in developing countries, availability of low cost CROs, increasing government support, shortage of trial volunteers in European and North American countries, and growth in the number of pharmaceutical companies are driving the growth of the eClinical solutions market in the Asia-Pacific region.

Get The Sample Copy Of This Report:

The major players in the global eClinical solutions market are PAREXEL International Corporation (U.S), BioClinica, Inc. (U.S), Oracle Corporation (U.S), CRF Health (U.S), DATATRAK International, Inc. (U.S), Medidata Solutions, Inc. (U.S), PHT Corporation (U.S), eResearch Technology (U.S), Merge Healthcare Incorporated (U.S), and OmniComm Systems, Inc. (U.S).

About MarketsandMarkets:
MarketsandMarkets is world’s No. 2 firm in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors.

M&M’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. The new included chapters on Methodology and Benchmarking presented with high quality analytical infographics in our reports gives complete visibility of how the numbers have been arrived and defend the accuracy of the numbers.

We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.

Subscribe Reports from Healthcare Domain @

Mr. Rohan

Unit No. 802, 8th Floor,
Tower - 7, Magarpatta City SEZ,
Hadapsar, Pune – 411013,
Maharashtra, India.
Tel: +1-888-6006-441.
Visit MarketsandMarkets Blog @
Connect with us on LinkedIn @